Racecadotril vs standard care for childhood diarrhea
Part of Digestive system clinical trials.
This study tests whether the medicine racecadotril can help children recover faster from acute watery diarrhea compared to standard treatment. It is for hospitalized children aged 3 months to 5 years whose diarrhea started within the past 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 months and 5 years old.
- The diarrhea started in the last 24 hours.
- The diarrhea is watery (not bloody or with mucus).
- Your child does not have severe dehydration or unstable vital signs.
- No known allergy to the study medicine (racecadotril).
- Your child has not been treated for this diarrhea before joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called rifaximin, taken along with oral rehydration solution, helps children aged 6 to 11 recover faster from acute (short-lasting) diarrhea that is likely caused by a bacterial infection. The study compares rifaximin plus oral rehydration versus oral rehydration alone.
This study compares different combinations of diarrhea treatments to find the best way to help children ages 6 months to 5 years with sudden diarrhea. If your child has acute diarrhea without severe dehydration or other serious health issues, they may be able to join.
This study tests a new type of oral rehydration drink for children with diarrhea. It aims to help kids recover faster at home without needing a hospital stay.
This trial compares rifaximin or azithromycin (both antibiotics) taken as a single dose, with loperamide to control symptoms. It’s for people with recent, watery diarrhea who can be treated and followed as an outpatient, to see which option works better and is safer.
This trial tests whether a single-strain probiotic (Bacillus Clausii) works better than a multi-strain probiotic for treating acute watery diarrhea in children aged 1 to 5 years. It aims to find which option helps children recover faster.
This trial tests whether eluxadoline can reduce symptoms of IBS with diarrhea (IBS-D) in children ages 6 to 17. It also asks families to track symptoms with a daily diary to measure whether treatment helps over the study period.
Hear when a new Diarrhoea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.